Purifying the benzohydrazide intermediate by THF-alcohol crystallization cuts impurities C and F and improves Indomethacin reproducibility.
Controlled precipitation in THF and C1-C4 alcohol reduces Impurities C and F below 0.15% each before indomethacin conversion.
Formula I compounds treat resistant protozoan infections while eliminating adverse effects from conventional agents.
Alkoxycarbonylation of halogenated intermediates followed by hydrazine reaction produces 3-methyl-1,2,4-thiadiazole-5-carbohydrazide.
Chemical synthesis of ramalin using protected L-glutamic acid prevents decomposition during storage when stabilized with vitamin C.
Diarylacetylene hydrazides inhibit T315I mutant Abl kinase, reducing cardiac toxicity.
Azido-containing polymer coatings enable covalent attachment of bioactive materials via click chemistry reactions with unsaturated compounds.
Hydrazide nucleating agents increase the net melting endotherm of polylactic acid, resolving suboptimal thermal properties.